Phio Pharmaceuticals Corporation

Phio Pharmaceuticals Corporation Aktie

Investor Relations Website
WKN: A40GMU
ISIN: US71880W5013
Marktkapitalisierung Help -
Streubesitz 73,98%
KGV -
Index-Zuordnung
-
EQS-News: Phio Pharmaceuticals Corp. Selected as B2i Digital Featured Company